Alicia Morgans, MD
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:MerckMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:DendreonMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:ClovisMitigation strategy:DivestDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:JanssenMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:GenetechMitigation strategy:DivestDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:SanofiMitigation strategy:DivestDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:AstellasMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Astra ZenecaMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:BayerMitigation strategy:Peer reviewDate reviewed:08/07/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:GenetechMitigation strategy:Peer reviewDate reviewed:08/07/2023